106 related articles for article (PubMed ID: 30278287)
1. Predicting the location of the non-local contacts in α-synuclein.
Bergasa-Caceres F; Rabitz HA
Biochim Biophys Acta Proteins Proteom; 2018 Dec; 1866(12):1201-1208. PubMed ID: 30278287
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein misfolding and neurodegenerative diseases.
Uversky VN
Curr Protein Pept Sci; 2008 Oct; 9(5):507-40. PubMed ID: 18855701
[TBL] [Abstract][Full Text] [Related]
3. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
Uversky VN
J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
[TBL] [Abstract][Full Text] [Related]
4. C. elegans as a Model for Synucleinopathies and Other Neurodegenerative Diseases: Tools and Techniques.
Koopman M; Seinstra RI; Nollen EAA
Methods Mol Biol; 2019; 1948():93-112. PubMed ID: 30771173
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
Paleologou KE; Irvine GB; El-Agnaf OM
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1106-10. PubMed ID: 16246056
[TBL] [Abstract][Full Text] [Related]
6. Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity.
Angelova DM; Brown DR
Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30071596
[TBL] [Abstract][Full Text] [Related]
7. The Interaction of Alpha-synuclein with Membranes and its Implication in Parkinson's Disease: A Literature Review.
Gonzalez-Horta A
Nat Prod Commun; 2015 Oct; 10(10):1775-8. PubMed ID: 26669123
[TBL] [Abstract][Full Text] [Related]
8. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
[TBL] [Abstract][Full Text] [Related]
9. Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein.
Janowska MK; Wu KP; Baum J
Sci Rep; 2015 Oct; 5():15164. PubMed ID: 26477939
[TBL] [Abstract][Full Text] [Related]
10. Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases.
Chavarría C; Souza JM
Arch Biochem Biophys; 2013 May; 533(1-2):25-32. PubMed ID: 23454347
[TBL] [Abstract][Full Text] [Related]
11. Studies of the aggregation of an amyloidogenic alpha-synuclein peptide fragment.
Madine J; Doig AJ; Kitmitto A; Middleton DA
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1113-5. PubMed ID: 16246058
[TBL] [Abstract][Full Text] [Related]
12. Contact between the β1 and β2 Segments of α-Synuclein that Inhibits Amyloid Formation.
Shaykhalishahi H; Gauhar A; Wördehoff MM; Grüning CS; Klein AN; Bannach O; Stoldt M; Willbold D; Härd T; Hoyer W
Angew Chem Int Ed Engl; 2015 Jul; 54(30):8837-40. PubMed ID: 26119103
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of alpha-synuclein neurodegeneration.
Waxman EA; Giasson BI
Biochim Biophys Acta; 2009 Jul; 1792(7):616-24. PubMed ID: 18955133
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein and tau: teammates in neurodegeneration?
Moussaud S; Jones DR; Moussaud-Lamodière EL; Delenclos M; Ross OA; McLean PJ
Mol Neurodegener; 2014 Oct; 9():43. PubMed ID: 25352339
[TBL] [Abstract][Full Text] [Related]
15. Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation.
Fonseca-Ornelas L; Eisbach SE; Paulat M; Giller K; Fernández CO; Outeiro TF; Becker S; Zweckstetter M
Nat Commun; 2014 Dec; 5():5857. PubMed ID: 25524885
[TBL] [Abstract][Full Text] [Related]
16. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of nonspecific inhibitors of protein aggregation: dissecting the interactions of alpha-synuclein with Congo red and lacmoid.
Lendel C; Bertoncini CW; Cremades N; Waudby CA; Vendruscolo M; Dobson CM; Schenk D; Christodoulou J; Toth G
Biochemistry; 2009 Sep; 48(35):8322-34. PubMed ID: 19645507
[TBL] [Abstract][Full Text] [Related]
18. Refolding of helical soluble α-synuclein through transient interaction with lipid interfaces.
Rovere M; Sanderson JB; Fonseca-Ornelas L; Patel DS; Bartels T
FEBS Lett; 2018 May; 592(9):1464-1472. PubMed ID: 29633780
[TBL] [Abstract][Full Text] [Related]
19. Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.
Silva BA; Breydo L; Uversky VN
Mol Neurobiol; 2013 Apr; 47(2):446-59. PubMed ID: 22940885
[No Abstract] [Full Text] [Related]
20. Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis.
Tavassoly O; Lee JS
FEBS Lett; 2012 Sep; 586(19):3222-8. PubMed ID: 22771474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
